Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
After finishing at $4.3 in the prior trading day, Relmada Therapeutics Inc (NASDAQ: RLMD) closed at $4.26, down -0.93%. In other words, the price has decreased by -$0.93 from its previous closing price. On the day, 0.79 million shares were traded. RLMD stock price reached its highest trading level at $4.37 during the session, while it also had its lowest trading level at $3.99.
Ratios:
Our goal is to gain a better understanding of RLMD by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.86 and its Current Ratio is at 2.86. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
On December 05, 2024, Mizuho Downgraded its rating to Neutral which previously was Outperform and also lowered its target price recommendation from $23 to $1. Jefferies Upgraded its Hold to Buy on September 17, 2024, whereas the target price for the stock was revised from $3.50 to $13.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 05 ’25 when Shenouda Maged bought 500,000 shares for $2.20 per share. The transaction valued at 1,100,000 led to the insider holds 788,335 shares of the business.
Ence Chuck bought 136,000 shares of RLMD for $299,200 on Nov 05 ’25. The CAO and COO now owns 403,931 shares after completing the transaction at $2.20 per share. On Nov 05 ’25, another insider, TRAVERSA SERGIO, who serves as the Chief Executive Officer of the company, bought 272,500 shares for $2.20 each. As a result, the insider paid 599,500 and bolstered with 1,272,500 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RLMD now has a Market Capitalization of 312401248 and an Enterprise Value of 298514720.
Stock Price History:
The Beta on a monthly basis for RLMD is 0.58, which has changed by 0.48275864 over the last 52 weeks, in comparison to a change of 0.1177547 over the same period for the S&P500. Over the past 52 weeks, RLMD has reached a high of $5.12, while it has fallen to a 52-week low of $0.24. The 50-Day Moving Average of the stock is 66.73%, while the 200-Day Moving Average is calculated to be 298.44%.
Shares Statistics:
The stock has traded on average 1.33M shares per day over the past 3-months and 1395300 shares per day over the last 10 days, according to various share statistics. A total of 73.33M shares are outstanding, with a floating share count of 50.90M. Insiders hold about 30.59% of the company’s shares, while institutions hold 14.57% stake in the company. Shares short for RLMD as of 1763078400 were 946511 with a Short Ratio of 0.39, compared to 1760486400 on 562426. Therefore, it implies a Short% of Shares Outstanding of 946511 and a Short% of Float of 1.2999999.
Earnings Estimates
Analysts are recommending an EPS of between -$0.83 and -$0.83 for the fiscal current year, implying an average EPS of -$0.83. EPS for the following year is -$0.36, with 1.0 analysts recommending between -$0.36 and -$0.36.
